Genistein for mild cognitive impairment
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether a natural compound called genistein (found in soy) can improve memory and thinking in people with mild cognitive impairment who are at risk for Alzheimer's disease. You'd take genistein as a supplement, and the study would see if it helps slow down further decline.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 50 years old.
- You must have been diagnosed with mild cognitive impairment (MCI), meaning you have noticeable memory or thinking problems that are more than normal aging but not severe enough to be dementia.
- You must have had a brain scan (PET scan) showing that you have amyloid plaques, which are one of the hallmarks of Alzheimer's disease.
- You must not be taking supplements that contain isoflavones (like soy isoflavone supplements).
- You must not have certain other serious conditions, such as significant brain, blood vessel, or psychiatric diseases, or a cancer that is affected by hormones.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
This trial tests an oral supplement called gamma glutamylcysteine (GGC) in people with mild cognitive impairment (MCI) to see if it is safe and well-tolerated. It may help by supporting the body's natural defenses against cell damage.
This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.
This trial tests whether a dietary supplement made from olive polyphenols, combined with following a Mediterranean diet, can help protect thinking and memory in people with mild cognitive impairment (MCI). It may be a good fit if you have early memory changes and want to try a nutrition-based approach.
This study tests an experimental tablet called RP902 for people with mild cognitive impairment (early memory and thinking problems). The goal is to see if it can safely help slow down memory decline.
This trial tests whether a natural plant compound can help support memory and thinking in people at higher risk for Alzheimer's disease. You may qualify if you are over 50, overweight, eat a typical Western diet, and have a family history of Alzheimer's.
Hear when a new Alzheimer Disease (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.